Researchers map molecular details that encourage H1N1 transmission to humans

The 2009 H1N1 pandemic influenza virus appears to have required certain mutations in order to be transmitted to humans, according to a paper in the September Journal of Virology. The research could prove extremely valuable for efforts to predict human outbreaks. 

The 2009 was caused by a swine that mutated in a way that made it transmissible among humans. The researchers, led by Hualan Chen of the Harbin Veterinary Research Institute, Harbin, China, have determined the probable details of the mutations that led to human transmission. 

In this study, Chen, who is director of the National Reference Laboratory at the Institute, and her collaborators have shown that two specific mutations in each of two proteins appear to be critical to transmission to, and among humans. One of those mutations, of a single amino acid in the virus' hemagglutinin protein, gives the virus the ability to bind to human receptors, and enables transmission in mammals via droplets of respiratory fluids. 

That amino acid, in the 226th slot in the protein, is glutamine. The researchers showed its importance by causing a mutation from glutamine, the amino acid in that position seen in viruses from infected humans, to argenine, as seen in swine. Working in , the researchers showed that the switch dampened the virus' ability to bind the human receptor, while boosting its ability to bind to the avian receptor. They showed further that the change rendered the virus non-transmissible via respiratory droplets in guinea pig models, and unable to replicate in the lungs of ferrets—results that suggest, but do not prove that the same may happen in humans. 

Also in guinea pigs, changing an amino acid in the virus' PB2 protein abolished transmission in via respiratory droplets, while that change, plus another single amino acid change in the hemagglutinin protein, killed such transmission in ferrets. 

It gets still more convoluted. The same amino acid in the PB2 protein that enables virus transmission via respiratory droplets, which is located at position 271 in that protein, can also encourage the afore-mentioned mutation in hemagglutinin position 226 to glutamine, which enables the virus to cleave to the human receptor. 

The value of all this information, says Chen, is that it provides a means for predicting outbreaks of human-transmissible H1N1.

More information: Y. Zhang, et al., 2012. Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus. J. Virol. 86:9666-9674. bit.ly/asmtip0912b

add to favorites email to friend print save as pdf

Related Stories

The pandemic potential of H9N2 avian influenza viruses

Aug 13, 2008

Since their introduction into land-based birds in 1988, H9N2 avian influenza A viruses have caused multiple human infections and become endemic in domestic poultry in Eurasia. This particular influenza subtype has been evolving ...

Recommended for you

Africa's uneven health care becomes easy prey for Ebola

4 hours ago

Threatened by the possible spread of an Ebola epidemic which respects no borders, Africa is divided between a handful of countries equipped to withstand an outbreak and many more which would be devastated, experts say.

Ebola case stokes concerns for Liberians in Texas

5 hours ago

The first case of Ebola diagnosed in the U.S. has been confirmed in a man who recently traveled from Liberia to Dallas, sending chills through the area's West African community whose leaders urged caution ...

Is Australia prepared for Ebola?

8 hours ago

Australia needs to be proactive about potential disease outbreaks like Ebola and establish a national centre for disease control.

Dallas hospital confirms first Ebola case in US

14 hours ago

A patient at a Dallas hospital has tested positive for Ebola, the first case of the disease to be diagnosed in the United States, federal health officials announced Tuesday.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

gord4356
not rated yet Sep 20, 2012
I was with the Canadian Military in 2009, and was ordered to get the H1N1 shot (AREPANRIX by GSK GlaxoSmithKline). I had an adverse reaction to the vaccine which included PERMANENT neurological, cardiovascular, gastrointestinal, and respiratory symptoms. It's difficult to believe but I now have dizziness, vertigo, irregular heart rythyms, shortness of breath, muscle weakness and pain, and numbness moving up my body, to name but a few of the serious symptoms. I went from special forces fit to that of a 70 year old in a matter of days. Please choose wisely if you do plan to have your next flu shot or vaccination. You may also ask your doctor and other Heath care workers if they will be getting these shots. My doctor flat out said "no way".